Australia markets open in 2 hours 33 minutes

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
80.76-1.37 (-1.67%)
At close: 04:00PM EDT
80.76 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,471,644
2,419,226
2,096,039
1,846,275
1,860,455
Cost of revenue
504,562
514,854
483,669
470,515
524,272
Gross profit
1,967,082
1,904,372
1,612,370
1,375,760
1,336,183
Operating expenses
Research development
779,914
746,773
649,606
628,793
628,116
Selling general and administrative
952,183
937,300
854,000
759,400
737,700
Total operating expenses
1,792,925
1,746,273
1,566,406
1,450,093
1,428,016
Operating income or loss
174,157
158,099
45,964
-74,333
-91,833
Interest expense
16,585
16,741
15,377
14,744
27,480
Total other income/expenses net
14,616
-10,538
101,550
3,846
55,462
Income before tax
237,353
188,563
149,576
-75,350
-48,997
Income tax expense
31,898
20,918
8,015
-11,270
-903,026
Income from continuing operations
205,455
167,645
141,561
-64,080
854,029
Net income
205,455
167,645
141,561
-64,080
854,029
Net income available to common shareholders
205,455
167,645
141,561
-64,080
854,029
Basic EPS
0.77
0.89
0.76
-0.35
4.75
Diluted EPS
0.77
0.87
0.75
-0.35
4.53
Basic average shares
187,222
187,834
185,266
182,852
180,804
Diluted average shares
191,056
191,595
188,963
182,852
191,678